Christopher Causey serves as Executive at UNITED THERAPEUTICS CORP, where they oversee executive responsibilities. Since joining the company, Christopher Causey has executed 357 insider transactions totaling $24.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 4, 2007 involved exercising options for 1,250 shares valued at $39.3K.
Christopher Causey currently holds 7,320 shares of UNITED THERAPEUTICS CORP (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Causey has been a net seller of UTHR stock. They have purchased $0 and sold $24.5M worth of shares.
Christopher Causey's most recent insider trade was on May 4, 2007, when they sold 1,250 shares at $31.45 per share.
Get notified when new Form 4 filings are submitted
| $59.12 |
| Discretionary |
| Aug 7, 2006 | UTHR | $101.1K | Option Exercise | 4,000 | $25.28 | Discretionary |
| Aug 7, 2006 | UTHR | $219.2K | Sale | 4,000 | $54.79 | Discretionary |
| May 5, 2006 | UTHR | $221.3K | Sale | 4,000 | $55.32 | Discretionary |
| May 5, 2006 | UTHR | $101.1K | Option Exercise | 4,000 | $25.28 | Discretionary |
| Dec 29, 2005 | UTHR | $0 | Gift | 100 | $N/A | Discretionary |